Sartorius Stedim Biotech SA

Common Name
Sartorius Stedim Biotech
Country
France
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
10,030
Ticker
DIM
Exchange
EURONEXT
Description
Sartorius Stedim Biotech S.A. is a leading global provider in the biopharmaceutical sector, specializing in the design and manufacture of equipment and services to support the development, quality ass...

Sartorius Stedim Biotech's GHG Emissions Data Preview

In 2024, Sartorius Stedim Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Sartorius Stedim Biotech has also provided a category-level breakdown for 11 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Sartorius Stedim Biotech’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sartorius Stedim Biotech’s data sources below and access millions more through our Disclosure Search.

a. Sartorius Stedim Biotech's Universal Registration Document (URD) 2024
a. Sartorius Stedim Biotech's Universal Registration Document (URD) 2024

Insights into Sartorius Stedim Biotech's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Sartorius Stedim Biotech amounted to 54,492 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Sartorius Stedim Biotech's Scope 1 Emissions Over Time

202403.5 k7 k10.5 k14 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Sartorius Stedim Biotech's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Sartorius Stedim Biotech were 13,712 metric tons of CO₂ equivalent (tCO₂e). a

What are Sartorius Stedim Biotech's Scope 2 emissions?

In 2024, Sartorius Stedim Biotech reported Scope 2 greenhouse gas (GHG) emissions of 24,402 tCO₂e using the market-based method and 40,780 tCO₂e using the location-based method. a

What methodology does Sartorius Stedim Biotech use for Scope 2 reporting?

In 2024, Sartorius Stedim Biotech reported its Scope 2 emissions using the market-based method and using the location-based method. a

Sartorius Stedim Biotech's Scope 2 Emissions Over Time

2024015 k30 k45 k60 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Sartorius Stedim Biotech's Value Chain Emissions

In 2024, Sartorius Stedim Biotech reported 527,796 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of Sartorius Stedim Biotech includes a breakdown across 11 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in , reflecting improved emissions accounting practices and greater transparency across the company's value chain a

Sartorius Stedim Biotech's Scope 3 Emissions Over Time

20240150 k300 k450 k600 ktCO2e
  • Total Scope 3
  • Year-over-Year Change

What are Sartorius Stedim Biotech's Scope 3 emissions?

In 2024, Sartorius Stedim Biotech reported total Scope 3 emissions of 527,796 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 77.28% of these emissions originated from upstream activities such as purchased goods and capital goods, while 22.72% came from downstream activities like product use, distribution, and end-of-life treatment. a

What categories of Scope 3 emissions does Sartorius Stedim Biotech disclose?

In 2024, Sartorius Stedim Biotech reported emissions for 11 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Sartorius Stedim Biotech's Scope 3 emissions?

In 2024, the largest contributors to Sartorius Stedim Biotech's Scope 3 emissions were: a

  • Purchased Goods and Services (Cat. 1): 215,106 tCO₂e (40.76%)
  • Use of Sold Products (Cat. 11): 112,971 tCO₂e (21.4%)
  • Capital Goods (Cat. 2): 110,839 tCO₂e (21%)

Sartorius Stedim Biotech's Scope 3 Emissions by Categories

Use of Sold Products(Cat. 11)(21.4%)Capital Goods(Cat. 2)(21.0%)Purchased Goods andServices (Cat. 1)(40.8%)

Insights into Sartorius Stedim Biotech’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Sartorius Stedim Biotech reported Scope 1 greenhouse gas (GHG) emissions of 13,712 tCO₂e and total revenues of USD 2,893 millions. This translates into an emissions intensity of 4.74 tCO₂e per millions USD. a

Sartorius Stedim Biotech's Scope 1 Emissions Intensity Compared to Peers

51002,00050,0001,000,000Scope 1 Emissions (tCO2e)1005002,00010,000100,000Revenues (Millions of USD)ResmedYear: 2023Scope 1: 4,453 tCO2eRevenue: $M 4,223Scope 1 Intensity: 1.05 tCO2e/$MColoplastYear: 2024Scope 1: 17,514 tCO2eRevenue: $M 4,038Scope 1 Intensity: 4.34 tCO2e/$MAptargroupYear: 2023Scope 1: 24,660 tCO2eRevenue: $M 3,487Scope 1 Intensity: 7.07 tCO2e/$MHoyaYear: 2023Scope 1: 11,000 tCO2eRevenue: $M 5,511Scope 1 Intensity: 2.00 tCO2e/$MTerumoYear: 2023Scope 1: 64,123 tCO2eRevenue: $M 6,158Scope 1 Intensity: 10.41 tCO2e/$MAvantorYear: 2023Scope 1: 26,095 tCO2eRevenue: $M 6,967Scope 1 Intensity: 3.75 tCO2e/$MAlconYear: 2024Scope 1: 74,202 tCO2eRevenue: $M 7,992Scope 1 Intensity: 9.28 tCO2e/$MBausch + LombYear: 2024Scope 1: 51,517 tCO2eRevenue: $M 4,791Scope 1 Intensity: 10.75 tCO2e/$MFielmann GroupYear: 2024Scope 1: 6,362 tCO2eRevenue: $M 2,356Scope 1 Intensity: 2.70 tCO2e/$MGerresheimerYear: 2024Scope 1: 256,418 tCO2eRevenue: $M 2,151Scope 1 Intensity: 119.24 tCO2e/$MKossan Rubber IndustriesYear: 2023Scope 1: 212,743 tCO2eRevenue: $M 346Scope 1 Intensity: 614.41 tCO2e/$MWarby ParkerYear: 2023Scope 1: 961 tCO2eRevenue: $M 670Scope 1 Intensity: 1.43 tCO2e/$MCarl Zeiss MeditecYear: 2024Scope 1: 58,158 tCO2eRevenue: $M 2,308Scope 1 Intensity: 25.20 tCO2e/$MBaxter InternationalYear: 2024Scope 1: 324,000 tCO2eRevenue: $M 10,636Scope 1 Intensity: 30.46 tCO2e/$MConvaTec GroupYear: 2024Scope 1: 12,360 tCO2eRevenue: $M 1,690Scope 1 Intensity: 7.31 tCO2e/$MTeleflexYear: 2024Scope 1: 16,256 tCO2eRevenue: $M 3,047Scope 1 Intensity: 5.33 tCO2e/$MEssilorLuxotticaYear: 2024Scope 1: 116,092 tCO2eRevenue: $M 27,584Scope 1 Intensity: 4.21 tCO2e/$MAnsellYear: 2024Scope 1: 173,100 tCO2eRevenue: $M 2,475Scope 1 Intensity: 69.94 tCO2e/$MAddLifeYear: 2023Scope 1: 8,491 tCO2eRevenue: $M 960Scope 1 Intensity: 8.84 tCO2e/$MTecan GroupYear: 2024Scope 1: 2,010 tCO2eRevenue: $M 1,032Scope 1 Intensity: 1.95 tCO2e/$MAngelalign TechnologyYear: 2023Scope 1: 8 tCO2eRevenue: $M 229Scope 1 Intensity: 0.03 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MIntuitive SurgicalYear: 2024Scope 1: 8,105 tCO2eRevenue: $M 8,352Scope 1 Intensity: 0.97 tCO2e/$MHologicYear: 2024Scope 1: 7,050 tCO2eRevenue: $M 4,030Scope 1 Intensity: 1.75 tCO2e/$MSartorius Stedim BiotechYear: 2024Scope 1: 13,712 tCO2eRevenue: $M 2,893Scope 1 Intensity: 4.74 tCO2e/$M

How does Sartorius Stedim Biotech's GHG emissions intensity compare to its peers?

In 2024, Sartorius Stedim Biotech reported a Scope 1 emissions intensity of 4.74 tCO₂e per millions USD. Compared to the peer group median of 4.84 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Sartorius Stedim Biotech rank on GHG emissions intensity within its industry?

In 2024, Sartorius Stedim Biotech ranked 13 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Sartorius Stedim Biotech is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Insights into Sartorius Stedim Biotech's Total Carbon Footprint

In 2024, Sartorius Stedim Biotech reported a total carbon footprint of 582,288 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. a

The largest contributor to Sartorius Stedim Biotech's total carbon footprint was Scope 3 emissions, accounting for 90.64% of the company's total carbon footprint, followed by Scope 2 emissions at 7%. a

Want Full Access to Sartorius Stedim Biotech's GHG Emissions Dataset?
Sign Up